Vaccination did not protect cattle against bluetongue in the Netherlands

Published 2024년 7월 14일

Tridge summary

Dutch Agriculture Minister Femke Wiersma has raised concerns about the effectiveness of the bluetongue vaccine, as animals on several farms have fallen ill or died despite being vaccinated. The state veterinary service reports 67 farms with suspected cases, 20 confirmed and 47 pending tests. Although vaccinated animals exhibit milder symptoms, the vaccine primarily reduces symptoms and mortality rather than preventing infection. The Minister highlights that the vaccines were approved for their ability to lessen virus particles and severe symptoms. The veterinary organization KNMvD calls for reporting any side effects, and Wiersma expects the epidemic to peak in late August or early September.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Dutch Agriculture Minister Femke Wiersma warns in a letter to the House of Representatives that animals on several farms have become ill or even died, even though they were vaccinated against bluetongue. Doubts about the effectiveness of the vaccine are therefore fully justified, reports the agricultural portal Boerderij. Infections despite vaccinations Information from the state veterinary service shows that suspicions of bluetongue disease currently concern 67 farms where animals have been vaccinated. Test results confirmed the appearance of the virus in 20 of them, and blood samples from 47 other farms are still being tested by the Wningen Bioveterary Research (WBVR) laboratories. Confirmed cases concern sheep and cattle farming. In vaccinated herds, animals still show signs of bluetongue, but the symptoms are less severe. However, one sheep died. Tests have already shown that they were infected with the same bluetongue virus that was revealed last year when the first cases ...
Source: Farmer.pl

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.